Management

Robert E. Ward

President and Chief Executive Officer

Photo of Robert E. Ward

Robert E. Ward

President and Chief Executive Officer

Bob Ward joined Radius Health as president and chief executive officer in 2013. Bob has more than 25 years of experience in the biopharmaceutical industry on both the R&D and the business side of a number of leading companies. During his tenure, Radius Health has completed late stage development of its lead compound and filed the first global regulatory new drug applications, successfully raised over $750 million in private and public financings – including an initial public offering in 2014, and advanced other novel compounds/drug delivery technologies in clinical development. Mr. Ward is a member of the board of directors of Akari Therapeutics, where he chairs the nominating and governance committee. Prior to joining Radius, Mr. Ward was Vice President for Strategy and External Alliances for the New Opportunities iMed of AstraZeneca (AZ) focusing on areas outside of AZ’s historical therapeutic focus, including orphan drugs and endocrinology. After starting his career in the Molecular Biology discovery group at Genentech, Mr. Ward progressed through a series of management and executive roles with established biopharmaceutical companies including NPS Pharmaceuticals, Schering-Plough (Merck), and Bristol-Myers Squibb. Mr. Ward received a B.A. in Biology and a B.S. in Physiological Psychology, both from the University of California, Santa Barbara; an M.S. in Management from the New Jersey Institute of Technology; and an M.A. in Immunology from The Johns Hopkins University School of Medicine.